共 185 条
[1]
Afshar-Oromieh A(2016)The rise of PSMA ligands for diagnosis and therapy of prostate cancer J Nucl Med 57 79S-89S
[2]
Babich JW(2017)Diagnostic performance of (68)Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients Eur J Nucl Med Mol Imaging 44 1258-1268
[3]
Kratochwil C(2019)Metaanalysis of (68)Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology J Nucl Med 60 786-793
[4]
Giesel FL(2019)Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial JAMA Oncol 5 856-863
[5]
Eisenhut M(2019)Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis Skelet Radiol 48 1915-1924
[6]
Kopka K(2017)Prostate-specific membrane antigen ligands for imaging and therapy J Nucl Med 58 67S-76S
[7]
Afshar-Oromieh A(2012)[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH Eur J Nucl Med Mol Imaging 39 1085-1086
[8]
Holland-Letz T(2018)(68)Ga-PSMA-11 PET/CT in prostate cancer local recurrence: impact of early images and parametric analysis Am J Nucl Med Mol Imaging 8 351-359
[9]
Giesel FL(2016)(68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer Eur J Nucl Med Mol Imaging 43 1288-1299
[10]
Kratochwil C(2012)A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer EJNMMI Res 2 23-796